The Ministry of Industry and Information Technology announced that a total of 38 innovative drugs received market approval in the first half of the year. Among these approvals, 31 were domestic innovative drugs, accounting for more than 80% of the total.
Furthermore, outbound technology licensing for innovative drugs reached a new high during the same period, with the total transaction value surpassing 100 billion US dollars.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.